Ibrutinib Dimer
| Product Name | Ibrutinib Dimer |
|---|---|
| Alternate Names | Ibrutinib Impurities, Impurities of Ibrutinib |
| CAT No. | CS-O-16944 |
| CAS No. | 2031255-23-7 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 880.99 g/mol |
| Mol. For. | C₅₀H₄₈N₁₂O₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Ibrutinib |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Ibrutinib Dimer is a potent and selective inhibitor of Bruton tyrosine kinase (BTK) that is used in the treatment of various types of cancer. It is a dimeric form of ibrutinib, which was first approved by the FDA in 2013 for the treatment of mantle cell lymphoma. Ibrutinib Dimer has been found to be effective in the treatment of other types of cancer such as chronic lymphocytic leukemia, Waldenstrom's macroglobulinemia, and marginal zone lymphoma.
Chemically, Ibrutinib Dimer is a small molecule that belongs to the class of drugs known as kinase inhibitors. It works by blocking the activity of BTK, which is an enzyme that plays a crucial role in the growth and survival of cancer cells. By inhibiting BTK, Ibrutinib Dimer helps to slow down the growth and spread of cancer cells, thereby improving the prognosis for cancer patients.
The recommended dose of Ibrutinib Dimer varies depending on the type of cancer being treated and the patient's individual characteristics. The drug is administered orally and is available in tablet form. The most common side effects of Ibrutinib Dimer include diarrhea, nausea, fatigue, and headache.
In conclusion, Ibrutinib Dimer is a highly effective and targeted cancer treatment that has been found to be effective in the treatment of various types of cancer. Its mechanism of action and chemical properties make it a valuable addition to the armamentarium of anti-cancer drugs.
Get an Instant Quote
Related Compounds
Ibrutinib Impurity 12 | Ibrutinib impurity Dimer | Ibrutinib N1-Oxide | Ibrutinib Impurity L | Ibrutinib Hydroxy Impurity | N6-Acryloyl Ibrutinib | Ibrutinib Piperidine impurity | Ibrutinib Impurity 42 | N1-(2-Carboxyethyl) Ibrutinib | Ibrutinib Impurity 6 | Rac -Ibrutinib propionaldehyde | Ibrutinib (IBR) Diamine Impurity | Ibrutinib Di-piperidine impurity | ibrutinib acetyl impurity | N-Desacryloyl N-3-hydroxypropanoyl Ibrutinib | Ibrutinib Impurity 7 | Ibrutinib Michael addition adduct | Ibrutinib Impurity 1 | N-Desacryloyl N-(3-Acryloyl-propanoyl) Ibrutinib | Ibrutinib Impurity D | Ibrutinib Amino Piperidine dihydrochloride Impurity | Ibrutinib impurity 25 | Ibrutinib Impurity 9 | Ibrutinib N-Oxide impurity | Ibrutinib Impurity 8 | Ibrutinib Impurity 15 | Ibrutinib Piperidine N-desacryl impurity |